Comparison of Aflibercept Producers Derived from СНО and СНО-GS Cell Lines

When creating cell lines expressing recombinant proteins, the type of selection marker and selection conditions are of essential importance. In this work, we aim to obtain and compare cell lines based on CHO and CHO-GS as potential aflibercept producers to identify the most suitable cell line for obtain ing an aflibercept biosimilar. As a result, 10 monoclonal cell lines-producers of a potential aflibercept biosimilar were obtained based on СНО and CHO-GS cell platforms. In the two groups, the productivity on the 15th day of periodic cultivation with feeding achieved 2.5 g/L. The СНО-GS group showed an in crease in the specific cell productivity of aflibercept producers. The conclusion is made that the СНО-GS glutamine auxotroph line is a more preferable option. This cell line enables a comparable yield of target protein at lower concentrations of viable cells, which has a favorable effect on further stages of purification and isolation of target protein.

Authors

Publication Details

Journal
Journal Biomed
Published
2025-04-21
DOI
https://doi.org/10.33647/2074-5982-21-1-46-57
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of Aflibercept Producers Derived from СНО and СНО-GS Cell Lines

R. L. Anisimov, Хамитов Равиль Авгатович, D. T. Zaripova, S. S. Timonova et al.
Journal Biomed
Immunotherapy and Immune Responses
article

Comparison of Aflibercept Producers Derived from СНО and СНО-GS Cell Lines

R. L. Anisimov, Хамитов Равиль Авгатович, D. T. Zaripova, S. S. Timonova, Aleksandr Piskunov, I. A. Kirik, R. I. Farsieva, I. A. Kargopolov
article en

Abstract

When creating cell lines expressing recombinant proteins, the type of selection marker and selection conditions are of essential importance. In this work, we aim to obtain and compare cell lines based on CHO and CHO-GS as potential aflibercept producers to identify the most suitable cell line for obtain ing an aflibercept biosimilar. As a result, 10 monoclonal cell lines-producers of a potential aflibercept biosimilar were obtained based on СНО and CHO-GS cell platforms. In the two groups, the productivity on the 15th day of periodic cultivation with feeding achieved 2.5 g/L. The СНО-GS group showed an in crease in the specific cell productivity of aflibercept producers. The conclusion is made that the СНО-GS glutamine auxotroph line is a more preferable option. This cell line enables a comparable yield of target protein at lower concentrations of viable cells, which has a favorable effect on further stages of purification and isolation of target protein.

Journal BiomedVol. 21(1)
Openalex Percentile: Top 91%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.